Literature DB >> 17228326

Progranulin mutations in Dutch familial frontotemporal lobar degeneration.

Iraad F Bronner1, Patrizia Rizzu, Harro Seelaar, Saskia E van Mil, Burcu Anar, Asma Azmani, Laura Donker Kaat, Sonia Rosso, Peter Heutink, John C van Swieten.   

Abstract

Mutations in the progranulin (PGRN) gene have recently been identified in frontotemporal lobar degeneration with ubiquitin inclusions linked to chromosome 17q21. We report here the finding of two novel frameshift mutations and three possible pathogenic missense mutations in the PGRN gene. Furthermore, we determined the frequency of PGRN mutations in familial cases recruited from a large population-based study of frontotemporal lobar degeneration carried out in The Netherlands.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17228326     DOI: 10.1038/sj.ejhg.5201772

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  21 in total

Review 1.  Update on recent molecular and genetic advances in frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2008-07       Impact factor: 3.685

2.  Frequency of progranulin mutations in a German cohort of 79 frontotemporal dementia patients.

Authors:  Johannes Carolus Magnus Schlachetzki; Klaus Schmidtke; Jan Beckervordersandforth; Wiktor Borozdin; Christian Wilhelm; Michael Hüll; Jürgen Kohlhase
Journal:  J Neurol       Date:  2009-07-19       Impact factor: 4.849

3.  The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.

Authors:  Chang-En Yu; Thomas D Bird; Lynn M Bekris; Thomas J Montine; James B Leverenz; Ellen Steinbart; Nichole M Galloway; Howard Feldman; Randall Woltjer; Carol A Miller; Elisabeth McCarty Wood; Murray Grossman; Leo McCluskey; Christopher M Clark; Manuela Neumann; Adrian Danek; Douglas R Galasko; Steven E Arnold; Alice Chen-Plotkin; Anna Karydas; Bruce L Miller; John Q Trojanowski; Virginia M-Y Lee; Gerard D Schellenberg; Vivianna M Van Deerlin
Journal:  Arch Neurol       Date:  2010-02

Review 4.  The genetics of frontotemporal lobar degeneration.

Authors:  Rosa Rademakers; Mike Hutton
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

5.  The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family.

Authors:  Salvatore Spina; Martin R Farlow; Frederick W Unverzagt; David A Kareken; Jill R Murrell; Graham Fraser; Francine Epperson; R Anthony Crowther; Maria G Spillantini; Michel Goedert; Bernardino Ghetti
Journal:  Brain       Date:  2007-12-07       Impact factor: 13.501

Review 6.  The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments.

Authors:  Ian R A Mackenzie; Rosa Rademakers
Journal:  Neurogenetics       Date:  2007-09-06       Impact factor: 2.660

7.  Brain progranulin expression in GRN-associated frontotemporal lobar degeneration.

Authors:  Alice S Chen-Plotkin; Jiping Xiao; Felix Geser; Maria Martinez-Lage; Murray Grossman; Travis Unger; Elisabeth M Wood; Vivianna M Van Deerlin; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2009-08-02       Impact factor: 17.088

8.  Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.

Authors:  Harro Seelaar; Kirsten Y Klijnsma; Inge de Koning; Aad van der Lugt; Wang Zheng Chiu; Asma Azmani; Annemieke J M Rozemuller; John C van Swieten
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

9.  Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways.

Authors:  Iraad F Bronner; Zoltán Bochdanovits; Patrizia Rizzu; Wouter Kamphorst; Rivka Ravid; John C van Swieten; Peter Heutink
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

10.  A decade of genetic counseling in frontotemporal dementia affected families: few counseling requests and much familial opposition to testing.

Authors:  S R Riedijk; M F N Niermeijer; D Dooijes; A Tibben
Journal:  J Genet Couns       Date:  2009-04-10       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.